Seattle Genetics



Ebitda Zmiana Data
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 22.24M 10.04M 2025-03
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Amgen USD 3.75B 42M 2025-03
Astellas Pharma JPY 110.79B 173.83B 2025-03
Bayer EUR 3.59B 1.92B 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Celldex Therapeutics USD -61872000 6.66M 2025-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eisai JPY 8.81B 28.8B 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Exelixis USD 194.2M 23.1M 2025-04
Genmab DKK 204M 2.03B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 222.66M 97.54M 2025-03
Insmed USD -226016000 15.78M 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Moderna USD -924000000 69M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Sanofi EUR 2.86B 2.3B 2025-03
Sarepta Therapeutics USD -290408000 472.62M 2025-03
Takeda JPY 128.14B 126.45B 2025-03
Teva Pharmaceutical Industries USD 1.11B 848M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Xencor USD -36907000 44.05M 2025-03



Seattle Genetics - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.